Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Investors concerned about sticky inflation should look to high-yield dividend stocks in sectors that will continue to ...

Vertex's lineup will look transformed in five years, and the company should continue performing well beyond that time. It's ...

Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.

The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year. The ...

Harmony Biosciences' Wakix shows promise for significant revenue growth. Find out why HRMY stock’s profitability and pipeline ...

Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone ...

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...

For people who study the opioid epidemic, 2025 marks a grim anniversary: It has been 30 years since the Food and Drug ...

From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024.

CORAL GABLES, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced its inclusion in Forbes' esteemed list of America's Most ...

Recruiters and observers in the market compared Kirkland’s move into Philadelphia with Goodwin Procter’s 2023 entry.